Castleman's tumor and erosive lichen planus: Coincidence or association?

Ashinoff, Robin; Cohen, Russell W.; Lipkin, George

doi:10.1016/s0190-9622(89)70299-1

Cited by 28 publications

(9 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surgery was the treatment of choice frequently followed by complete or incomplete remission of clinical symptoms; in 2 cases |22, 231, in which there was no evidence of pemphigus, surgical treatment failed to control the disease. In 1 patient with skin lesions suggestive of erosive lichen planus which showed striking similarities with our case [15], the underlying neo plasm was regarded as inoperable. This leads to the specu lation that, retrospectively, some of these cases may rcllect paraneoplastic pemphigus.…”

Section: Discussionsupporting

confidence: 63%

See 1 more Smart Citation

Paraneoplastic Pemphigus with Clinical Features of Erosive Lichen planus Associated with Castleman’s Tumor

Jansen

Plewig

Anhalt³

1995

Dermatology

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 63%

“…In summary, pemphigus was diagnosed in 6 patients |5, 14. 17, 19-21), lichen planus in 2 [5,15). Surgery was the treatment of choice frequently followed by complete or incomplete remission of clinical symptoms; in 2 cases |22, 231, in which there was no evidence of pemphigus, surgical treatment failed to control the disease.…”

Section: Discussionmentioning

confidence: 99%

Paraneoplastic Pemphigus with Clinical Features of Erosive Lichen planus Associated with Castleman’s Tumor

Jansen

Plewig

Anhalt³

1995

Dermatology

View full text Add to dashboard Cite

show abstract

“…Associated oral erosive lichen planus and pemphigus also have been reported in patients with MCD. 10 CD can be histologically divided into 3 types: hyaline vascular, plasma cell, and mixed. The hyaline vascular type is present in more than 90% of patients with CD and is typically found in patients with a diagnosis of UCD, 11 which commonly affects a single lymph node.…”

Section: Discussionmentioning

confidence: 99%

Castleman Disease of the Parotid Gland: A Case Report

Liu¹,

Wang²,

Wei-Xian³

2020

Journal of Oral and Maxillofacial Surgery

View full text Add to dashboard Cite

Castleman disease is a rare lymphoproliferative disorder characterized by the formation of painless hyperplastic lymph nodes. It can affect any lymph nodes of the body but rarely affects the salivary gland. We describe a patient with unicentric Castleman disease presenting as a parotid tumor and discuss the diagnosis and treatment of Castleman disease. A 39-year-old man had a painless lump on the right side of his face for 1 year. A computed tomography scan showed a well-defined, homogeneous mass in the right parotid gland. The patient underwent a right-sided superficial parotidectomy with preservation of the facial nerve. Histopathologic analysis of the excisional biopsy specimen confirmed the diagnosis of Castleman disease. No further treatment was administered, and the patient recovered well; no recurrence was present at the 1-year follow-up. Castleman disease is a lymphoproliferative disease that rarely affects the parotid gland. Histopathologic examination is regarded as the gold standard for diagnosis of Castleman disease. The current treatment for patients with unicentric Castleman disease is surgical resection. For patients with multicentric Castleman disease, more complex therapies are required.

show abstract

“…Grinspan described seven cases of OLP associated with diabetes and hypertension (Grinspan et al, 1966), a triad which became known as Grinspan's syndrome. This is still seen but is probably a coincidental combination of the three common disorders or may be a lichenoid reaction provoked by the drugs used to control diabetes or hypertension (Lamey et al, 1990 (Helm et al, 1994), retroperitoneal sarcoma (Helm et al, 1994), stomach cancer (Okoki et al, 1990), thymoma (Tan, 1974a,b;Aronson et al, 1978;Flamenbaum et al, 1982;Cottoni et al, 1988;Helm et al 1994), Castleman's tumor (Ashinoff et al, 1989;Jansen et al, 1995), craniopharyngioma (Magnusson, 1967), pituitary adenoma (Magnusson, 1967), and non-Hodgkin's lymphoma (Feuerman and Sandbank, 1971;Helm et al, 1994).…”

Section: (8) Stressmentioning

confidence: 99%

Update On Oral Lichen Planus: Etiopathogenesis and Management

Scully

Beyli²,

Ferreiro

et al. 1998

Critical Reviews in Oral Biology & Medicine

470

461

View full text Add to dashboard Cite

Lichen planus (LP) is a relatively common disorder of the stratified squamous epithelia, which is, in many ways, an enigma. This paper is the consensus outcome of a workshop held in Switzerland in 1995, involving a selection of clinicians and scientists with an interest in the condition and its management. The oral (OLP) eruptions usually have a distinct clinical morphology and characteristic distribution, but OLP may also present a confusing array of patterns and forms, and other disorders may clinically simulate OLP. Lesions may affect other mucosae and/or skin. Lichen planus is probably of multifactorial origin, sometimes induced by drugs or dental materials, often idiopathic, and with an immunopathogenesis involving T-cells in particular. The etiopathogenesis appears to be complex, with interactions between and among genetic, environmental, and lifestyle factors, but much has now been clarified about the mechanisms involved, and interesting new associations, such as with liver disease, have emerged. The management of lichen planus is still not totally satisfactory, and there is as yet no definitive treatment, but there have been advances in the control of the condition. There is no curative treatment available; immunomodulation, however, can control the condition. Based on the observed increased risk of malignant development, OLP patients should be offered regular follow-up examination from two to four times annually and asked to report any changes in their lesions and/or symptoms. Follow-up may be particularly important in patients with atrophic/ulcerative/erosive affections of the tongue, the gingiva, or the buccal mucosa. Much more research is required into the genetic and environmental aspects of lichen planus, into the premalignant potential, and into the possible associations with chronic liver, and other, disorders. More clinical studies are required into the possible efficacy of immunomodulatory drugs such as pentoxifylline and thalidomide.

show abstract

Castleman's tumor and erosive lichen planus: Coincidence or association?

Cited by 28 publications

References 20 publications

Paraneoplastic Pemphigus with Clinical Features of Erosive Lichen planus Associated with Castleman’s Tumor

Paraneoplastic Pemphigus with Clinical Features of Erosive Lichen planus Associated with Castleman’s Tumor

Castleman Disease of the Parotid Gland: A Case Report

Update On Oral Lichen Planus: Etiopathogenesis and Management

Contact Info

Product

Resources

About